B&K Corp Ltd is a CN-based company operating in industry. The company is headquartered in Qingdao, Shandong and currently employs 100 full-time employees. The company went IPO on 2025-12-22. B&K Corp Ltd is a China-based company principally engaged in the research and development of biopharmaceutical products. The firm committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The firm primarily focus on the discovery, development and commercialization of therapies for wound healing, currently platelet-derived growth factor (PDGF) drugs. The firm mainly operates its businesses in the domestic market.
02396.HK stock price ended at $0 on 星期日, after dropping NaN%
On the latest trading day Feb 15, 2026, the stock price of 02396.HK fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for 02396.HK decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.